company background image
ACUS logo

Acusphere OTCPK:ACUS Stock Report

Last Price

US$0.000001

Market Cap

US$4.0

7D

0%

1Y

n/a

Updated

22 Mar, 2024

Data

Company Financials

ACUS Stock Overview

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs.

ACUS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Acusphere, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Acusphere
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.000001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

ACUSUS PharmaceuticalsUS Market
7D0%0.3%1.9%
1Yn/a25.0%31.1%

Return vs Industry: Insufficient data to determine how ACUS performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how ACUS performed against the US Market.

Price Volatility

Is ACUS's price volatile compared to industry and market?
ACUS volatility
ACUS Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: ACUS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ACUS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993n/an/ahttps://www.acusphere.com

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension.

Acusphere, Inc. Fundamentals Summary

How do Acusphere's earnings and revenue compare to its market cap?
ACUS fundamental statistics
Market capUS$4.00
Earnings (TTM)-US$69.42m
Revenue (TTM)US$2.68m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACUS income statement (TTM)
RevenueUS$2.68m
Cost of RevenueUS$34.45m
Gross Profit-US$31.77m
Other ExpensesUS$37.65m
Earnings-US$69.42m

Last Reported Earnings

Dec 31, 2008

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did ACUS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.